Should we adjudicate outcomes in stroke trials? A systematic review.

Peter J Godolphin Philip M BathAlan A Montgomery

Published in: International journal of stroke : official journal of the International Stroke Society (2022)

Central adjudication may not be necessary in stroke trials with blinded outcome assessment. However, for open-label studies, central adjudication may be more important.

Keyphrases

atrial fibrillation
open label
clinical trial
study protocol
cerebral ischemia
randomized controlled trial
squamous cell carcinoma
type diabetes
metabolic syndrome
phase iii
radiation therapy
placebo controlled
skeletal muscle
insulin resistance
double blind